Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 198 articles:
HTML format



Single Articles


    September 2021
  1. GREDIC M, Wu CY, Hadzic S, Pak O, et al
    Myeloid cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice.
    Eur Respir J. 2021 Sep 2. pii: 13993003.01153-2021.
    PubMed     Abstract available


    August 2021
  2. OLSSON KM, Hoeper MM, Pausch C, Grunig E, et al
    Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01483-2021.
    PubMed    


  3. KIELY DG, Condliffe R
    Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow.
    Eur Respir J. 2021;58.
    PubMed    


  4. DECLERCQ M, Treps L, Bousfia S, Carmeliet P, et al
    Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
    Eur Respir J. 2021;58.
    PubMed    


  5. SAVALE L, Akagi S, Tu L, Cumont A, et al
    Serum and pulmonary uric acid in pulmonary arterial hypertension.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    July 2021
  6. MORRELL NW
    Screening asymptomatic BMPR2 mutation carriers: a new frontier for pulmonary hypertension physicians?
    Eur Respir J. 2021;58.
    PubMed    


  7. MONTANI D, Girerd B, Jais X, Laveneziana P, et al
    Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    June 2021
  8. ABMAN SH, Mullen MP, Sleeper LA, Austin ED, et al
    Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.
    Eur Respir J. 2021 Jun 17. pii: 13993003.03337-2020.
    PubMed     Abstract available


  9. LAUNAY D, Sanges S, Sobanski V
    Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    


  10. PEREZ-OLIVARES C, Segura de la Cal T, Flox-Camacho A, Nuche J, et al
    The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease.
    Eur Respir J. 2021;57.
    PubMed    


  11. BAUER Y, de Bernard S, Hickey P, Ballard K, et al
    Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    May 2021
  12. STEWART S, Chan YK, Playford D, Strange GA, et al
    Mild pulmonary hypertension and premature mortality among 154 956 men and women undergoing routine echocardiography.
    Eur Respir J. 2021 May 28. pii: 13993003.00832-2021.
    PubMed     Abstract available


  13. AWADA C, Grobs Y, Wu WH, Habbout K, et al
    R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models.
    Eur Respir J. 2021;57.
    PubMed    


  14. RAHAGHI FN, Hilton JF, Correa RA, Loureiro C, et al
    Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    


    April 2021
  15. OLDHAM WM, Hess E, Waldo SW, Humbert M, et al
    Integrating hemodynamics identifies an extreme pulmonary hypertension phenotype.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04625-2020.
    PubMed    


  16. LLUCIA-VALLDEPERAS A, van Wezenbeek J, Goumans MJ, de Man FS, et al
    The battle of new biomarkers for right heart failure in pulmonary hypertension: is the queen of hearts NT-proBNP defeated at last?
    Eur Respir J. 2021;57.
    PubMed    


  17. AMSALLEM M, Sweatt AJ, Arthur Ataam J, Guihaire J, et al
    Targeted proteomics of right heart adaptation to pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  18. MACIAS D, Moore S, Crosby A, Southwood M, et al
    Targeting HIF2alpha-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    February 2021
  19. ULRICH S, Grunig E
    The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment.
    Eur Respir J. 2021;57.
    PubMed    


  20. BORGESE M, Badesch D, Bull T, Chakinala M, et al
    EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  21. LEWIS RA, Armstrong I, Bergbaum C, Brewis MJ, et al
    EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    January 2021
  22. SWINNEN K, Bijnens E, Casas L, Nawrot TS, et al
    Residential air pollution increases the risk for persistent pulmonary hypertension after pulmonary endarterectomy.
    Eur Respir J. 2021 Jan 21. pii: 13993003.02680-2020.
    PubMed    


  23. REMY-JARDIN M, Ryerson CJ, Schiebler ML, Leung ANC, et al
    Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  24. BOGAARD HJ, Sitbon O
    Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
    Eur Respir J. 2021;57.
    PubMed    


  25. HAARMAN MG, Levy M, Roofthooft MTR, Douwes JM, et al
    Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    December 2020
  26. DELCROIX M, Torbicki A, Gopalan D, Sitbon O, et al
    ERS Statement on Chronic Thromboembolic Pulmonary Hypertension.
    Eur Respir J. 2020 Dec 17. pii: 13993003.02828-2020.
    PubMed     Abstract available


    November 2020
  27. KERANOV S, Dorr O, Jafari L, Troidl C, et al
    CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.
    Eur Respir J. 2020 Nov 12. pii: 13993003.01192-2019.
    PubMed     Abstract available


  28. CONDLIFFE R, Kiely DG, Lewis RA
    Mild parenchymal lung disease is still lung disease.
    Eur Respir J. 2020;56.
    PubMed    


  29. GODINAS L, Harari S, Barbera JA, Montani D, et al
    Mild parenchymal lung disease is still lung disease.
    Eur Respir J. 2020;56.
    PubMed    


  30. RHODES CJ
    The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?
    Eur Respir J. 2020;56.
    PubMed    


    October 2020
  31. CAMBOULIVE A, Jutant EM, Savale L, Jais X, et al
    Reversible pulmonary hypertension associated with multivisceral Whipple's disease.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03132-2020.
    PubMed    


  32. SWIETLIK EM, Ghataorhe P, Zalewska KI, Wharton J, et al
    Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2020 Oct 15. pii: 13993003.03201-2020.
    PubMed     Abstract available


    September 2020
  33. BADAGLIACCA R, Vizza CD
    Imaging risk in pulmonary arterial hypertension.
    Eur Respir J. 2020;56.
    PubMed    


    August 2020
  34. GUIGNABERT C, Humbert M
    Targeting Transforming Growth Factor Beta Receptors in Pulmonary Hypertension.
    Eur Respir J. 2020 Aug 13. pii: 13993003.02341-2020.
    PubMed     Abstract available


  35. ADIR Y, Humbert M, Chaouat A
    Sleep-related breathing disorders and pulmonary hypertension.
    Eur Respir J. 2020 Aug 3. pii: 13993003.02258-2020.
    PubMed     Abstract available


  36. SOFIANOPOULOU E, Church C, Coghlan G, Howard L, et al
    Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
    Eur Respir J. 2020;56.
    PubMed    


    July 2020
  37. JEVNIKAR M, Montani D, Savale L, Seferian A, et al
    Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems.
    Eur Respir J. 2020 Jul 16. pii: 13993003.02208-2020.
    PubMed    


  38. MARON BA, Humbert M
    Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
    Eur Respir J. 2020;56.
    PubMed    


    June 2020
  39. NEWNHAM M, Bunclark K, Abraham N, Ali S, et al
    CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension (CTEPH).
    Eur Respir J. 2020 Jun 8. pii: 13993003.02096-2019.
    PubMed     Abstract available


  40. BEHR J, Hoeper MM
    Subtle signs - red flags.
    Eur Respir J. 2020;55.
    PubMed    


    May 2020
  41. OLSSON KM, Fuge J, Brod T, Kamp JC, et al
    Oral iron supplementation with ferric maltol in patients with pulmonary hypertension.
    Eur Respir J. 2020 May 22. pii: 13993003.00616-2020.
    PubMed    


  42. DODSON MW, Sumner K, Carlsen J, Cirulis MM, et al
    The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2020 May 22. pii: 13993003.00774-2020.
    PubMed    


  43. LICHTBLAU M, Saxer S, Furian M, Mayer L, et al
    Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m.
    Eur Respir J. 2020 May 19. pii: 13993003.02474-2019.
    PubMed     Abstract available


  44. SITBON O, Reis A, Humbert M, Vonk Noordegraaf A, et al
    Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration.
    Eur Respir J. 2020;55.
    PubMed    


  45. VIS D, Boucly A, Humbert M, Weatherald J, et al
    Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension?
    Eur Respir J. 2020;55.
    PubMed    


  46. AUSTIN ED, Elliott CG
    TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form.
    Eur Respir J. 2020;55.
    PubMed    


  47. JANSEN SMA, van den Heuvel L, Meijboom LJ, Alsters SIM, et al
    Correspondence regarding "T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease": a single-centre case series.
    Eur Respir J. 2020;55.
    PubMed    


  48. THORE P, Girerd B, Jais X, Savale L, et al
    Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  49. GHIO S, Crimi G, Guida S, Valentini A, et al
    Magnetic resonance imaging of pulmonary arterial compliance after pulmonary endarterectomy.
    Eur Respir J. 2020;55.
    PubMed    


    April 2020
  50. YOGESWARAN A, Richter MJ, Sommer N, Ghofrani HA, et al
    Evaluation of pulmonary hypertension by right heart catheterisation - does timing matter?
    Eur Respir J. 2020 Apr 29. pii: 13993003.01892-2019.
    PubMed    


  51. KIKUCHI H, Goda A, Takeuchi K, Inami T, et al
    Exercise intolerance in chronic thromboembolic pulmonary hypertension after pulmonary angioplasty.
    Eur Respir J. 2020 Apr 20. pii: 13993003.01982-2019.
    PubMed     Abstract available


  52. DUAN D, Gu C, Jun JC
    Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke?
    Eur Respir J. 2020;55.
    PubMed    


  53. TOSHNER M, Rothman A
    IL-6 in pulmonary hypertension: why novel is not always best.
    Eur Respir J. 2020;55.
    PubMed    


  54. BOTROS L, Vonk Noordegraaf A, Aman J
    Vanishing vessels aboding pulmonary disease: a role for VEGFR2.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  55. KLOK FA, Couturaud F, Delcroix M, Humbert M, et al
    Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Eur Respir J. 2020 Mar 17. pii: 13993003.00189-2020.
    PubMed     Abstract available


  56. SHLOBIN OA, Kouranos V, Barnett SD, Alhamad EH, et al
    Physiological Predictors of Survival in Patients with Sarcoidosis Associated Pulmonary Hypertension: Results from an International Registry.
    Eur Respir J. 2020 Mar 5. pii: 13993003.01747-2019.
    PubMed     Abstract available


  57. FRUMP AL, Lahm T
    Tips for success in pulmonary hypertension treatment: progress in isolating endothelial cells from pulmonary artery catheters.
    Eur Respir J. 2020;55.
    PubMed    


    February 2020
  58. PABST S, Grohe C, Skowasch D
    Prevalence of sarcoidosis-associated pulmonary hypertension: cumulative analysis of two PULSAR studies.
    Eur Respir J. 2020;55.
    PubMed    


    January 2020

  59. "Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease." Laurent Savale, Anoosha Habibi, Francois Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Gregoir
    Eur Respir J. 2020;55.
    PubMed    


    December 2019
  60. BOUVARD C, Genet N, Phan C, Rode B, et al
    Connexin 43 Is a Promising Target for Pulmonary Hypertension due To Hypoxemic Lung Disease.
    Eur Respir J. 2019 Dec 20. pii: 13993003.00169-2019.
    PubMed     Abstract available


  61. WAYPA GB, Schumacker PT
    Roles of HIF1 and HIF2 in pulmonary hypertension: it all depends on the context.
    Eur Respir J. 2019;54.
    PubMed    


    November 2019
  62. BOUCLY A, Morelot-Panzini C, Garcia G, Weatherald J, et al
    Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
    Eur Respir J. 2019 Nov 26. pii: 13993003.02108-2018.
    PubMed     Abstract available


  63. GRUNIG E, Benjamin N, Eichstaedt CA, Peacock AJ, et al
    Multicentre trials on specialised exercise training and rehabilitation are useful in patients with pulmonary hypertension.
    Eur Respir J. 2019;54.
    PubMed    


    October 2019
  64. LEVY M, Moshous D, Szezepanski I, Galmiche L, et al
    Pulmonary hypertension after bone marrow transplantation in children.
    Eur Respir J. 2019 Oct 24. pii: 13993003.00612-2019.
    PubMed     Abstract available



  65. "Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?" Irene M. Lang and Hiromi Matsubara. Eur Respir J 2019; 53: 1900843.
    Eur Respir J. 2019;54.
    PubMed    


  66. LANG IM, Matsubara H
    Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
    Eur Respir J. 2019;54.
    PubMed    


  67. JAIS X, Brenot P, Montani D, Fadel E, et al
    A roadmap for management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019;54.
    PubMed    


    September 2019
  68. SAVALE L, Habibi A, Lionnet F, Maitre B, et al
    Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00585-2019.
    PubMed     Abstract available


  69. HU CJ, Poth JM, Zhang H, Flockton A, et al
    Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00378-2019.
    PubMed     Abstract available


    August 2019
  70. KOVACS G, Olschewski H
    Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing?
    Eur Respir J. 2019;54.
    PubMed    


  71. HAARMAN MG, Kerstjens-Frederikse WS, Berger RMF
    The ever-expanding phenotypical spectrum of human TBX4 mutations: from toe to lung.
    Eur Respir J. 2019;54.
    PubMed    


    July 2019
  72. ABID S, Marcos E, Parpaleix A, Amsellem V, et al
    CCR2/CCR5-Mediated Macrophage-Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
    Eur Respir J. 2019 Jul 18. pii: 13993003.02308-2018.
    PubMed     Abstract available


  73. HUITEMA MP, Bakker ALM, Mager JJ, Rensing BJWM, et al
    Prevalence of pulmonary hypertension in pulmonary sarcoidosis; the first large European prospective study.
    Eur Respir J. 2019 Jul 18. pii: 13993003.00897-2019.
    PubMed    


  74. KURAKULA K, Sun XQ, Happe C, da Silva Goncalves Bos D, et al
    6-mercaptopurine, an agonist of Nur77, reduces progression of pulmonary hypertension by enhancing BMP signalling.
    Eur Respir J. 2019 Jul 4. pii: 13993003.02400-2018.
    PubMed     Abstract available


    June 2019
  75. JAAFAR S, Visovatti S, Young A, Huang S, et al
    Impact of the Revised Hemodynamic Definition on the Diagnosis of Pulmonary Hypertension in Patients with Systemic Sclerosis.
    Eur Respir J. 2019 Jun 13. pii: 13993003.00586-2019.
    PubMed     Abstract available


  76. MARON BA, Choudhary G, Tedford RJ, Brittain E, et al
    Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension.
    Eur Respir J. 2019;53.
    PubMed    


  77. NAEIJE R
    Pulmonary hypertension at high altitude.
    Eur Respir J. 2019;53.
    PubMed    


  78. THEILMANN AL, Ormiston ML
    Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
    Eur Respir J. 2019;53.
    PubMed    


    May 2019
  79. GALAMBOS C, Mullen MP, Shieh JT, Schwerk N, et al
    Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension.
    Eur Respir J. 2019 May 31. pii: 13993003.01965-2018.
    PubMed     Abstract available


  80. ULRICH S, Saxer S, Hasler ED, Schwarz EI, et al
    Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
    Eur Respir J. 2019 May 9. pii: 13993003.002762019.
    PubMed     Abstract available


  81. TELLO K, Ghofrani HA, Heinze C, Krueger K, et al
    A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease.
    Eur Respir J. 2019 May 9. pii: 13993003.02435-2018.
    PubMed    


  82. MCCORMACK MC, Mathai SC
    A crossroads between the heart and lungs: air pollution and pulmonary hypertension.
    Eur Respir J. 2019;53.
    PubMed    


  83. LANG IM, Matsubara H
    Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
    Eur Respir J. 2019;53.
    PubMed    


  84. BECK EM, Hatton ND, Ryan JJ
    Novel techniques for advancing our understanding of pulmonary arterial hypertension.
    Eur Respir J. 2019;53.
    PubMed    


    April 2019
  85. BRENOT P, Jais X, Taniguchi Y, Alonso CG, et al
    French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Apr 25. pii: 13993003.02095-2018.
    PubMed     Abstract available


  86. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    PubMed     Abstract available


  87. DE MAN FS, Handoko ML, Vonk-Noordegraaf A
    The unknown pathophysiological relevance of right ventricular hypertrophy in pulmonary arterial hypertension.
    Eur Respir J. 2019;53.
    PubMed    


    March 2019
  88. HUMBERT M, Farber HW, Ghofrani HA, Benza RL, et al
    Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Eur Respir J. 2019 Mar 28. pii: 13993003.02004-2018.
    PubMed     Abstract available


  89. CASCINO TM, McLaughlin VV, Richardson CR, Behbahani-Nejad N, et al
    Physical activity and quality of life in patients with pulmonary hypertension.
    Eur Respir J. 2019 Mar 17. pii: 13993003.00028-2019.
    PubMed    


  90. GERGES C, Gerges M, Lang IM
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed    


  91. GRIGNOLA JC, Trujillo P, Domingo E
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed    


  92. GIBBS JSR, Torbicki A
    Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
    Eur Respir J. 2019;53.
    PubMed    


  93. HOEPER MM, Humbert M
    The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
    Eur Respir J. 2019;53.
    PubMed    


  94. ROSENZWEIG EB, Abman SH, Berger RMF
    Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Eur Respir J. 2019;53.
    PubMed    


  95. CALCATERRA G, Fanos V, Bassareo PP
    Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Eur Respir J. 2019;53.
    PubMed    


    January 2019
  96. NEWNHAM M, South K, Bleda M, Auger WR, et al
    The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01805-2018.
    PubMed     Abstract available


    December 2018
  97. GRUNIG E, Eichstaedt C, Barbera JA, Benjamin N, et al
    ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00332-2018.
    PubMed     Abstract available


  98. EYRIES M, Montani D, Nadaud S, Girerd B, et al
    Widening the landscape of heritable pulmonary hypertension mutations in pediatric and adult cases.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01371-2018.
    PubMed     Abstract available


  99. GALIE N, McLaughlin VV, Rubin LJ, Simonneau G, et al
    An overview of the 6th World Symposium on Pulmonary Hypertension.
    Eur Respir J. 2018 Dec 14. pii: 13993003.02148-2018.
    PubMed    


  100. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Abstract available


  101. HOEPER MM, Benza RL, Corris P, de Perrot M, et al
    Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01906-2018.
    PubMed     Abstract available


  102. MCGOON MD, Ferrari P, Armstrong I, Denis M, et al
    The importance of patient perspectives in pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01919-2018.
    PubMed     Abstract available


  103. VONK NOORDEGRAAF A, Chin KM, Haddad F, Hassoun PM, et al
    Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01900-2018.
    PubMed     Abstract available


  104. VACHIERY JL, Tedford RJ, Rosenkranz S, Palazzini M, et al
    Pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01897-2018.
    PubMed     Abstract available


  105. FROST A, Badesch D, Gibbs JSR, Gopalan D, et al
    Diagnosis of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01904-2018.
    PubMed     Abstract available


  106. HUMBERT M, Guignabert C, Bonnet S, Dorfmuller P, et al
    Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01887-2018.
    PubMed     Abstract available


  107. KIM NH, Delcroix M, Jais X, Madani MM, et al
    Chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01915-2018.
    PubMed     Abstract available


  108. SIMONNEAU G, Montani D, Celermajer DS, Denton CP, et al
    Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01913-2018.
    PubMed     Abstract available


    November 2018
  109. KLOK FA, Barco S, Konstantinides SV, Dartevelle P, et al
    Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01687-2018.
    PubMed    


  110. SWIETLIK EM, Ruggiero A, Fletcher AJ, Taboada D, et al
    Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01787-2018.
    PubMed    


    October 2018
  111. DELCROIX M, Staehler G, Gall H, Grunig E, et al
    Risk assessment in medically treated Chronic Thromboembolic Pulmonary Hypertension patients.
    Eur Respir J. 2018 Oct 18. pii: 13993003.00248-2018.
    PubMed     Abstract available


  112. TURPIN M, Chantalat-Auger C, Parent F, Driss F, et al
    Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.
    Eur Respir J. 2018;52.
    PubMed     Abstract available


    September 2018
  113. KIM NH, Mayer E
    Pulmonary endarterectomy and the cost of patient refusal.
    Eur Respir J. 2018;52.
    PubMed    


    August 2018
  114. GRUNE J, Kuebler WM
    Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension?
    Eur Respir J. 2018;52.
    PubMed    


    July 2018
  115. SOUMAGNE T, Guillien A, Chambellan A, Hua-Huy T, et al
    Global Lung Initiative equations in pulmonary hypertension screening in systemic sclerosis.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00528-2018.
    PubMed    


  116. QUADERY SR, Swift AJ, Billings C, Thompson A, et al
    The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00589-2018.
    PubMed     Abstract available


  117. BELLAYE PS, Yanagihara T, Granton E, Sato S, et al
    Macitentan reduces progression of TGF-beta1-induced pulmonary fibrosis and pulmonary hypertension.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01857-2017.
    PubMed    


    June 2018
  118. BADLAM JB, Austin ED
    Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed    


  119. GUIGNABERT C, de Man F, Lombes M
    ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad.
    Eur Respir J. 2018;51.
    PubMed    


  120. BAIRD GL, Archer-Chicko C, Barr RG, Bluemke DA, et al
    Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


    May 2018
  121. KING CS, Brown AW, Shlobin OA, Weir N, et al
    Prevalence and Impact of WHO Group 3 Pulmonary Hypertension in Advanced Idiopathic Nonspecific Interstitial Pneumonia.
    Eur Respir J. 2018 May 17. pii: 13993003.00545-2018.
    PubMed    


  122. GUAZZI M
    Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms.
    Eur Respir J. 2018;51.
    PubMed    


  123. HOEPER MM, Boucly A, Sitbon O
    Age, risk and outcomes in idiopathic pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed    


    April 2018
  124. HOEPER MM
    Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
    Eur Respir J. 2018;51.
    PubMed    


  125. CONDLIFFE R, Kovacs G
    Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.
    Eur Respir J. 2018;51.
    PubMed    


    March 2018
  126. GERGES C, Gerges M, Fesler P, Maria Pistritto A, et al
    In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Mar 29. pii: 13993003.00067-2018.
    PubMed     Abstract available


  127. COGHLAN G, Wolf M, Distler O, Denton CP, et al
    Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Eur Respir J. 2018 Mar 21. pii: 13993003.01197-2017.
    PubMed     Abstract available


  128. BONNET S, Boucherat O
    The ROS controversy in hypoxic pulmonary hypertension revisited.
    Eur Respir J. 2018;51.
    PubMed    


  129. OLSCHEWSKI H, Kovacs G, Herve P
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed    


  130. LANGLEBEN D, Orfanos SE
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed    


  131. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed    


  132. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed    


  133. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed    


    February 2018
  134. CARAVITA S, Dewachter C, Soranna D, Carolino D'Araujo S, et al
    Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.
    Eur Respir J. 2018 Feb 8. pii: 13993003.02427-2017.
    PubMed    


  135. PAK O, Scheibe S, Esfandiary A, Gierhardt M, et al
    Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01024-2017.
    PubMed     Abstract available


  136. HSU S, Tedford RJ
    Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed    


  137. VACHIERY JL, Delcroix M, Al-Hiti H, Efficace M, et al
    Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


    January 2018
  138. TRAMPER J, Nossent EJ, Lely RJ, Krouwels FH, et al
    Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed    


  139. COTTIN V, Price LC, Valenzuela C
    The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Eur Respir J. 2018;51.
    PubMed    


  140. KUMAR R, Graham B
    How does inflammation contribute to pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed    


    October 2017
  141. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    PubMed    


  142. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  143. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


    September 2017
  144. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    PubMed    


  145. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed    


    August 2017
  146. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


    July 2017
  147. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed    


    June 2017
  148. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    May 2017
  149. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed    


  150. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed    


  151. KLOK FA, Hoeper MM
    Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.
    Eur Respir J. 2017;49.
    PubMed    


    March 2017
  152. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    February 2017
  153. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    PubMed    


  154. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    PubMed    


  155. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  156. NAKHLEH MK, Haick H, Humbert M, Cohen-Kaminsky S, et al
    Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    December 2016
  157. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    PubMed     Abstract available


    November 2016
  158. RIOU M, Seferian A, Savale L, Chaumais MC, et al
    Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
    Eur Respir J. 2016;48:1517-1519.
    PubMed    


    October 2016
  159. EID-LIDT G, Gaspar J, Sandoval J, Gonzalez-Pacheco H, et al
    Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00910-2016. doi: 10.1183/13993003.00910-2016
    PubMed    


    September 2016

  160. "New potential diagnostic biomarkers for pulmonary hypertension." Svenja L. Tiede, Henning Gall, Oliver Dorr, Marina dos Santos Guilherme, Christian Troidl, Christoph Liebetrau, Sandra Voss, Robert Voswinckel, Ralph T. Schermuly, Werner Seeger, Friedr
    Eur Respir J. 2016;48:962.
    PubMed    


  161. LEVY M, Eyries M, Szezepanski I, Ladouceur M, et al
    Genetic analyses in a cohort of children with pulmonary hypertension.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00211-2016. doi: 10.1183/13993003.00211-2016.
    PubMed     Abstract available


    August 2016
  162. NAGARAJ C, Tang B, Nagy BM, Papp R, et al
    Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.
    Eur Respir J. 2016 Aug 18. pii: ERJ-01814-2015. doi: 10.1183/13993003.01814-2015
    PubMed     Abstract available


  163. GAMEN E, Seeger W, Pullamsetti SS
    The emerging role of epigenetics in pulmonary hypertension.
    Eur Respir J. 2016 Aug 4. pii: ERJ-01714-2015. doi: 10.1183/13993003.01714-2015.
    PubMed     Abstract available



  164. ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016;48:E68.
    PubMed    


    July 2016
  165. PARPALEIX A, Amsellem V, Houssaini A, Abid S, et al
    Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Eur Respir J. 2016 Jul 13. pii: ERJ-01448-2015. doi: 10.1183/13993003.01448-2015
    PubMed     Abstract available


    June 2016
  166. HASSOUN PM, Nathan SD
    Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.
    Eur Respir J. 2016;47:1615-7.
    PubMed    


    May 2016
  167. GERGES M, Gerges C, Lang IM
    How to define pulmonary hypertension due to left heart disease.
    Eur Respir J. 2016 May 12. pii: ERJ-00432-2016. doi: 10.1183/13993003.00432-2016
    PubMed    


    April 2016
  168. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Abstract available


  169. NEDER JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, et al
    Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01948-2015. doi: 10.1183/13993003.01948-2015
    PubMed    


  170. MATHAI SC, Ghofrani HA, Mayer E, Pepke-Zaba J, et al
    Quality of life in patients with chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01626-2015. doi: 10.1183/13993003.01626-2015
    PubMed     Abstract available


  171. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    PubMed     Abstract available


    March 2016
  172. GODINAS L, Lau EM, Chemla D, Lador F, et al
    Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01678-2015. doi: 10.1183/13993003.01678-2015
    PubMed    


  173. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Abstract available


    February 2016
  174. LAHM T
    Sex differences in pulmonary hypertension: are we cleaning up the mess?
    Eur Respir J. 2016;47:390-3.
    PubMed    


  175. TOSHNER M
    Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
    Eur Respir J. 2016;47:388-9.
    PubMed    


  176. MALENFANT S, Perros F
    beta-blockers in pulmonary arterial hypertension: generation might matter.
    Eur Respir J. 2016;47:682-4.
    PubMed    


  177. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed    


  178. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed    


  179. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Abstract available


  180. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Abstract available


    January 2016
  181. KOVACS G, Avian A, Olschewski H
    Proposed new definition of exercise pulmonary hypertension decreases false positive cases.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01394-2015. doi: 10.1183/13993003.01394-2015.
    PubMed    


  182. QUILOT FM, Georges M, Favrolt N, Beltramo G, et al
    Pulmonary hypertension associated with ponatinib therapy.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01110-2015. doi: 10.1183/13993003.01110-2015.
    PubMed    


  183. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    PubMed     Abstract available


    December 2015
  184. SABOOR F, Reckmann AN, Tomczyk CU, Peters DM, et al
    Nestin-expressing vascular wall cells drive development of pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00574-2015. doi: 10.1183/13993003.00574-2015
    PubMed     Abstract available


  185. GIRERD B, Montani D, Jais X, Eyries M, et al
    Genetic counselling in a national referral centre for pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00717-2015. doi: 10.1183/13993003.00717-2015
    PubMed     Abstract available



  186. "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)."
    Eur Respir J. 2015;46:1855-6.
    PubMed    


  187. SAVALE L, Chaumais MC, Sitbon O, Humbert M, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1851-3.
    PubMed    


  188. PRELLA M, Yerly P, Nicod LP, Aubert JD, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1849-51.
    PubMed    


    November 2015
  189. BARBERA JA, Blanco I
    Gaining insights into pulmonary hypertension in respiratory diseases.
    Eur Respir J. 2015;46:1247-50.
    PubMed    


    October 2015
  190. HUITEMA MP, Spee M, Vorselaars VM, Boerman S, et al
    Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Eur Respir J. 2015 Oct 22. pii: ERJ-01319-2015. doi: 10.1183/13993003.01319-2015
    PubMed    



  191. ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension.
    Eur Respir J. 2015;46:E58.
    PubMed    


  192. LAU EM, Tamura Y, McGoon MD, Sitbon O, et al
    The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress.
    Eur Respir J. 2015;46:879-82.
    PubMed    


    June 2015
  193. MANDERS E, Ruiter G, Bogaard HJ, Stienen GJ, et al
    Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.
    Eur Respir J. 2015;45:1737-40.
    PubMed    


  194. ROBERTSON HT
    Dead space: the physiology of wasted ventilation.
    Eur Respir J. 2015;45:1704-16.
    PubMed     Abstract available


    April 2015
  195. HUERTAS A, Tu L, Thuillet R, Le Hiress M, et al
    Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Eur Respir J. 2015;45:1066-80.
    PubMed     Abstract available


    March 2015
  196. HOUSTON BA, Tedford RJ
    Stressing the stepchild: assessing right ventricular contractile reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:604-7.
    PubMed    


  197. SHARMA T, Lau EM, Choudhary P, Torzillo PJ, et al
    Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:700-8.
    PubMed     Abstract available


    January 2015
  198. COURAND PY, Pina Jomir G, Khouatra C, Scheiber C, et al
    Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:139-49.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: